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Systems biology relies on data sets inwhich the same group
of proteins is consistently identiﬁed and precisely quanti-
ﬁed across multiple samples, a requirement that is only
partially achieved by current proteomics approaches.
Selected reaction monitoring (SRM)—also called multiple
reaction monitoring—is emerging as a technology that
ideally complements the discovery capabilities of shotgun
strategies by its unique potential for reliable quantiﬁcation
of analytes of low abundance in complex mixtures. In an
SRM experiment, a predeﬁned precursor ion and one of its
fragments are selected by the two mass ﬁlters of a triple
quadrupole instrumentandmonitoredovertimeforprecise
quantiﬁcation. A series of transitions (precursor/fragment
ion pairs) in combination with the retention time of the
targeted peptide can constitute a deﬁnitive assay. Typically,
a large number of peptides are quantiﬁed during a single
LC-MS experiment. This tutorial explains the application of
SRM for quantitative proteomics, including the selection of
proteotypic peptides and the optimization and validation of
transitions. Furthermore, normalization and various fac-
tors affecting sensitivity and accuracy are discussed.
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Introduction
Biology in general and systems biology in particular increas-
inglyrequirethe detectionandquantiﬁcation oflargenumbers
of analytes. Proteomic studies are commonly performed using
a shotgun approach, in which the sample proteins are
enzymatically degraded to peptides, which are then analysed
by mass spectrometry (MS). Thereby, a subset of the peptides
present in the sample is automatically and in part stochasti-
cally selected by the mass spectrometer in a process referred
to as data-dependent precursor selection. Systems biology
requires accurate quantiﬁcation of a speciﬁed set of peptides/
proteins across multiple samples derived from cells in
differentially perturbed states (Ideker et al, 2001). This
stringent requirement is driven by the long-term goal of
systems biology to generate mathematical models that
simulate the system and make speciﬁc predictions about its
behaviour under different conditions. Although the compre-
hensive quantitative analysis of the transcriptome has become
routine using microarray technology and other transcript
proﬁling technologies (Katagiri and Glazebrook, 2004),
quantitative proteomic analyses to a similar depth and
consistency have not been achieved by the current shotgun
proteomicapproaches. Besidestheir limitedsensitivity,amain
shortcoming of these methods is poor reproducibility of target
selection, which results in the identiﬁcation of only partially
overlapping sets of proteins from substantially similar
samples. Such fragmentary data sets are also unsatisfactory
forapplicationsapartfromsystemsbiology,inwhichcomplete
quantiﬁcation proﬁles for each of the quantiﬁed proteins are
required. Therefore, new approaches are needed to deliver
precise quantitative data from deﬁned sets of proteins reliably,
across multiple samples.
Selected reaction monitoring (SRM) has the potential to
overcome,atleastinpart,theshortcomingsofcurrentshotgun
proteomic approaches (See Box I for an overview of MS-based
quantiﬁcation methods). SRM exploits the unique capabilities
of triple quadrupole (QQQ) MS for quantitative analysis.
In SRM, the ﬁrst and the third quadrupoles act as ﬁlters to
speciﬁcally select predeﬁned m/z values corresponding to the
peptide ion and a speciﬁc fragmention of the peptide, whereas
the second quadrupole serves as collision cell (Figure 1).
Several such transitions (precursor/fragment ion pairs) are
monitored over time, yielding a set of chromatographic traces
with the retention time and signal intensity for a speciﬁc
transitionascoordinates.Thetwolevelsofmassselectionwith
narrow mass windowsresult in a high selectivity, as co-eluting
background ions are ﬁltered out very effectively. Unlike in
otherMS-based proteomic techniques,no fullmass spectraare
recorded in QQQ-based SRM analysis. The non-scanning
nature of this mode of operation translates into an increased
sensitivity by one or two orders of magnitude compared with
conventional ‘full scan’ techniques. In addition, it results in a
linear response over a wide dynamic range up to ﬁve orders of
magnitude. This enables the detection of low-abundance
proteins in highly complex mixtures, which is crucial for
systematic quantitative studies.
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QQQ MS ideally suited to address a major proteomic challenge
in systems biology: the accurate quantiﬁcation of predeﬁned
sets of proteins spanning the whole range of the cellular
proteome in a reproducible manner.
Establishing a proteomic SRM experiment
In contrast to conventional shotgun proteomic studies, SRM
measurements are quantitative analyses strictly targeting a
predetermined set of peptides and depend on speciﬁc SRM
transitions for each targeted peptide. Previous information is
required to deﬁne these transitions. Speciﬁcally, three types of
information are of critical importance. First, the proteins that
constitute the targeted protein set have to be selected. Second,
for each targeted protein, those peptides that present good MS
responses and uniquely identify the targeted protein, or a
speciﬁc isoform thereof, have to be identiﬁed. Such peptides
have been termed as proteotypic peptides (PTPs) (Mallick
et al, 2007). Third, for each PTP, those fragment ions that
provide optimal signal intensity and discriminate the targeted
peptide from other species present in the sample have to be
identiﬁed. These optimized transitions are the essence of an
SRM assay. The time and effort required to establish these
conditions is the price to pay for the excellent quantitative
performance of SRM-based experiments. However, once
established, such assays can be used indeﬁnitely in any study
that involves the particular targeted protein. The following
sections guide the reader through the different steps of an SRM
experiment (Figure 2).
Selection of a target protein set
The ﬁrst step of a targeted proteomic experiment is the
selection of a set of proteins of interest. Depending on the
sensitivity and accuracy required, hundreds and eventually up
to 1000 proteins can be targeted in a single LC-MS analysis
after the transitions have been optimized (see Box II). The
selection of the protein set might be on the basis of previous
experiments or the scientiﬁc literature. In addition, multiple
The simplest method to quantify analytes by LC-MS is the use of eXtracted
Ion Chromatograms (XIC). Data are collected in full MS scan mode and
processedpost-acquisition,toreconstructtheelutionproﬁlefortheion(s)of
interest, with a given m/z value and a tolerance. XIC peak heights or peak
areas are used to determine the analyte abundance.
Selected ion monitoring (SIM) is performed on scanning mass
spectrometers, by restricting the acquisition mass range around the m/z
value of the ion(s) of interest. The narrower the mass range, the more
speciﬁctheSIMassay.SIMexperimentsaremoresensitivethanXICsfrom
full scans because the MS is allowed to dwell for a longer time over a small
mass range of interest. Several ions within a given m/z range can be
observed without any discrimination and cumulatively quantiﬁed;
quantiﬁcation is still performed using ion chromatograms.
Selected reaction monitoring (SRM) is a non-scanning technique,
generally performed on triple-quadrupole (QQQ) instruments in which
fragmentation is used as a means to increase selectivity. In SRM
experiments, twomass analysers areusedasstaticmassﬁlters, tomonitor
a particular fragment ion of a selected precursor ion. The selectivity
resulting from the two ﬁltering stages combined with the high-duty cycle
resultsinquantitativeanalyseswithunmatchedsensitivity.Thespeciﬁcpair
of m/z values associated with the precursor and fragment ions selected is
referred to as a ‘transition’ (e.g., 673.5/534.3).
The term SRM or ‘pseudo SRM’ is occasionally used also to describe
experiments conducted in LITs or QqTOFs instruments where, upon
fragmentation of a precursor ion, MS/MS data are acquired on a partial
massrangecentredonafragmention.Althoughthisscanmoderesembles
an SRM experiment, it is based on the ‘electronic’ extraction of the
fragment ion signal(s) and can thus be essentially viewed as the SIM of
fragmention(s).ThefullpotentialofSRMasdescribedinthisreviewisonly
tapped when the experiment is performed on QQQ MS.
Multiplexed SRM transitions can be measured within the same
experiment on the chromatographic time scale by rapidly cycling through
a series of different transitions and recording the signal of each transition
as a function of elution time. The method allows for additional selectivity by
monitoring the chromatographic coelution of multiple transitions for a given
analyte. The term multiple reaction monitoring (MRM) is frequently used to
describe such parallel acquisition of SRM transitions, but it has been
deprecated by the IUPAC nomenclature (current Provisional Recommen-
dations, August 2006) (Murray et al, 2006).
Box 1 MS-based techniques for quantitative analyses
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Figure 1 SRM/MRM analysis on QQQ MS. Several analytes are coeluting from the chromatographic system. The speciﬁc m/z selection in the ﬁrst quadrupole ﬁlters
outmostcoelutingions.However,owingtoidenticalmass,oneinterferingion(blue)remains.Inquadrupole2,theanalytesarefragmented.Them/zselectioninthethird
quadrupole ﬁlters out all the fragments of the blue analyte and leaves only a particular fragment of the green analyte for speciﬁc detection.
Proteins of interest
Quantitative analysis by SRM
Proteotypic peptides
Validate peptides by SRM-
triggered MS2 experiments
Get heavy labelled peptides 
Choose and optimize transitions
Prediction
Shotgun results
PeptideAtlas
Figure 2 Workﬂow of SRM-based proteomic experiments.
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potentially relevant proteins, for example, gene expression
and protein expression data, protein–protein interaction data
or sets of functionally related proteins derived from gene
ontologygroupsorbasedontheKEGGdatabase.Alternatively,
network expansion can be used to complement an initial set of
proteins that might be discovered in quantitative proteome
screens (see Table I for links and citations).
Inadditiontotheproteinsofinterest,several‘housekeeping’
proteins should be selected as an invariant reference set to
correct experimental variability such as uneven total protein
amount per sample (see below). As the selection of the target
protein set depends on the objective of each study and is
therefore subjective, it is not further discussed here.
Peptide selection
Each of the targeted proteins yields tens to hundreds of
peptides upon tryptic digestion (Picotti et al, 2007). Typically,
only a few representative peptides per protein are targeted to
infer the presence of a protein in a sample and to determine its
quantity. The careful choice of the targeted peptides is
essential for the success of the SRM experiment. Several
factors affecting this choice are discussed in the following
section. Additional useful empirical rules for the selection of
peptides for SRM have been described earlier (Bronstrup,
2004; Kirkpatrick et al, 2005).
MS properties
It has been reported that among the peptides generated by
tryptic digestion of a protein, only a (small) subset is routinely
observed(Kusteretal,2005).Inprinciple,allpossiblepeptides
could be systematically tested. In practice, the time required
for assay development is signiﬁcantly reduced if previous
information isused toselect thosepeptidesthat aremostlikely
observed in the experiment and provide the strongest speciﬁc
signals. Previous information derived from the combination of
multiple shotgun proteomics experiments can be used in two
ways: the direct observation of highly detectable peptides and
the inference of rules that predict MS observability. For a
growing number of organisms, a signiﬁcant number of MS
experiments has been performed and the data have been
depositedinonlinerepositorieslikethe‘PeptideAtlas’,‘Human
Proteinpedia’,‘GPM Proteomics Database’ or ‘PRIDE’, which
support the retrieval of frequently observed peptides for the
identiﬁed proteins (see Table II for links and citations). The
recently released ‘ISPIDER Central’ enables querying across
several repositories. An intrinsic challenge of repositories is
the difﬁculty to guarantee high data quality. In particular, the
compilation of many similar experiments without researching
the original data may increase the false discovery rates
dramaticallyandthereforemisleadintheselectionofpeptides.
The same data resources have also been used to train
computational tools that attempt to predict the most likely
MS-observable peptides from proteins so far not covered
in the databases (Tang et al, 2006; Mallick et al, 2007). In
Table I Online information resources relevant to selection of a set of proteins of interest
Gene expression GEO http://www.ncbi.nlm.nih.gov/geo/ Barrett et al (2007)
Protein expression ProteinAtlas http://www.proteinatlas.org/ Uhlen and Ponten (2005)
Gene ontology groups GO http://www.geneontology.org/ Ashburner et al (2000)
Functional groups KEGG http://www.genome.jp/kegg/ Kanehisa and Goto (2000)
Protein–protein interactions IntAct http://www.ebi.ac.uk/intact/ Kerrien et al (2007)
Protein–protein interactions MINT http://mint.bio.uniroma2.it/ Chatr-aryamontri et al (2007)
Network expansion PhosphoPep http://www.phosphopep.org/ Bodenmiller et al (2007)
When targeting many proteins requiring numerous transitions in a single experiment, the dwell time of the individual transition is reduced. Therefore, the total
number of targeted peptides that are reliably quantiﬁable within an LC run is limited and depends on the requirements for the limit of detection to be achieved.
Practical dwell-time settings range between 10ms for good sensitivity and 100ms for excellent sensitivity. To ensure precise LC-MS quantiﬁcation, at least eight
data points should be acquired across the chromatographic elution proﬁle of a peptide. Assuming a peak width of 20s at 10% peak height, a cycle time of 2s is
required. This translates into 200 transitions of 10ms dwell time. If every protein should be quantiﬁed by 2 peptides with 2 transitions each, 50 proteins can be
quantiﬁed in total. In scheduled SRM, the transitions for a particular peptide are only acquired in a time window around the expected retention time, signiﬁcantly
increasing the number of peptides/proteins that can be detected and quantiﬁed in a single LC-MS experiment. More than 1000 transitions may be quantiﬁed with
high sensitivity and reproducibility using scheduled SRM.
Box 2 Quantiﬁcation of multiple proteins by SRM
Proteins Peptides/protein Peptides Transitions/peptide Transitions Cycle time (s) Dwell time (ms)
5 2 10 2 20 2 100
50 2 100 2 200 2 10
200 1 200 2 400 4 10
250 2 500 2 1000 2 30
a
1000 1 1000 2 2000 2 15
a
250 2 500 4 2000 2 15
a
aInscheduled SRMexperiments,thedwelltime dependsonthenumberoftransitionstargetedin aspeciﬁc timewindowand isthereforevariableovertheLCrun.
Average dwell times are calculated assuming an even distribution of the peptide retention times spread over 30min and a 2min time window for acquisition of
each transition.
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identify the most promising targets for SRM, even though
observability and signal intensity in SRM experiments do not
correlate perfectly. The observability in shotgun experiments
is largely inﬂuenced by the fragmentation characteristics.
Indeed, large peptides with many fragments of similar
intensities are identiﬁed with high conﬁdence. In contrast,
more intense SRM signals are obtained from peptides yielding
a few predominant fragments. Therefore, shorter peptides and
those containing proline residues are better targets for SRM,
even though their observability in shotgun experiments might
be lower than longer peptides ionized with similar efﬁciency.
Uniqueness
By selecting peptides for targeted MS analysis, it is essential to
ensurethat the peptidesselected uniquely identify thetargeted
protein or one isoform thereof. Additionally, it might be
important to select peptides that can distinguish different
splice isoforms or single nucleotide polymorphisms (SNP’s).
Both Ensembl (www.ensembl.org/) and NCBI (www.ncbi.
nlm.nih.gov/sites/entrez, www.ncbi.nlm.nih.gov/projects/
SNP/) databases provide information about splice variants
and SNPs. The PeptideAtlas (www.peptideatlas.org/) helps to
distinguish between multiple splice isoforms and distinct
genes by reporting the number of genome locations for
observed peptides and provides an interface to visualize
the peptide–protein relationship by cytoscape (Shannon et al,
2003).
Post-translational modiﬁcations
Modiﬁed peptides cannot be detected by SRM unless
speciﬁcally targeted. Quantitative differences observed in the
analysis of an unmodiﬁed peptide reﬂect either a true change
in abundance of the targeted protein in the samples or the
(partial) modiﬁcation of the peptide. Therefore, for reliable
quantiﬁcation, at least two peptides should be monitored for
each targeted protein. If two peptides from the same protein
reproducibly show divergent regulations, this is indicative of
(post-translational) modiﬁcation or processing of one of the
peptides. SRM can also be applied to speciﬁcally target and
quantify peptides with post-translational modiﬁcations like
phosphorylation (Unwin et al, 2005; Williamson et al, 2006),
ubiquitination (Mollah et al, 2007) or acetylation (Grifﬁths
et al, 2007), provided that transitions for those peptides are
established.
Chemically induced modiﬁcations
The introduction of artifactual chemical modiﬁcations due to
sample processing is a potential source of error in quantitative
MS experiments because a fraction of the targeted peptide
mightbeconvertedintothemodiﬁedforminanirreproducible
and unpredictable manner. Therefore, care should be taken to
avoid targeting peptides with a high propensity for artifactual
modiﬁcations. In particular, peptides containing methionine
ortryptophanresiduesshould beavoided, asthesidechainsof
these amino acids are prone to oxidation. Furthermore,
peptides containing glutamine or asparagine residues may be
chemically unstable and convert to glutamate or aspartate.
The rate of conversion is dependent on the surrounding
sequence, for example, asparagine followed by glycine or
proline is particularly prone to deamidation (Piszkiewicz et al,
1970; Geiger and Clarke, 1987). In addition, N-terminal
glutamine residues are quickly transformed to pyro-glutamate
under acidic conditions.
Cleavage sites
Despite the high speciﬁcity and efﬁciency of trypsin, peptides
with missed cleavages or non-tryptic cleavage sites are
frequently observed in shotgun analyses (Picotti et al, 2007).
Fortunately, for the most part, the ion current of such peptides
is relatively low compared with the ion current of the true
tryptic peptides. Such peptides should not be targeted for
absolute quantiﬁcation, as the extent of these events might be
variable between samples. However, such peptides might be
targetedascorroboratingevidenceforthepresenceofaprotein
in cases in which true tryptic PTPs are difﬁcult to detect. In
addition, peptides with two neighbouring basic amino acids at
eithercleavage site of the proteinsequence (e.g., KRNGGGRor
RNGGGKK) should be avoided, as those sites are predestined
for a high rate of missed cleavages.
Selection of SRM transitions
The quantiﬁcation of a peptide by SRM requires the selection
of speciﬁc m/z settings for the ﬁrst and third quadrupole,
which, in combination, results in a highly sensitive and
selectivedetection of the peptide (BoxIII). The combination of
m/z setting for the ﬁrst and third quadrupole is referred to as
‘transition’. The m/z value of the ﬁrst quadrupole is
determined by the mass and the predominant charge state of
a peptide. In the third quadrupole, a particular fragment ion of
the peptide is selected. The mass of the canonical fragment
ions can be easily calculated. However, the intensities of
individual fragments derived from one precursor ion differ
substantially. To obtain a high-sensitivity assay, it is therefore
essential to select transitions speciﬁc for the most intense
fragments. Including transitions for all the major canonical
fragments in the assay limits the analysis to a few peptides, as
the total number of transitions per LC-MS run is limited (see
Table II Online repositories for proteomics data sets
PeptideAtlas http://www.peptideatlas.org/ Desiere et al (2006)
Human proteinpedia http://www.humanproteinpedia.org/ Mathivanan et al (2008)
GPM Proteomics database http://gpmdb.thegpm.org/ Craig et al (2004)
PRIDE http://www.ebi.ac.uk/pride/ Jones et al (2008)
ISPIDER central http://ispider.smith.man.ac.uk/ Siepen et al (2008)
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peptide are selected for quantitative assays. The selection of
these transitions might be either on the basis of data from
shotgun experiments or experimentally determined on the
QQQ instrument. Shotgun experiments can be exploited to
derive information about the predominant precursor
chargestateandtheMS/MSfragmentationpatternofatargeted
peptide. However, one needs to be aware that the ionization
conditions can affect the charge state distribution. Similarly,
thedistributionofrelativefragmentionintensitiesisdependent
on the type of instrument used and the operating parameters.
This is particularly relevant when ion trap derived data are
used to select transitions for a QQQ instrument. Owing to the
different mode of collision-induced activation in ion traps
compared with quadrupole collision cells, higher b-type ions
and doubly charged fragments are usually less prominent or
absent in the QQQ instrument mass spectra.
Alternatively, the fragment ion masses of the targeted
peptide can be calculated and experimentally tested by SRM
measurements on a QQQ instrument. This yields the most
reliable selection of high-performing transitions. However, if
two precursor charge states and several ion series are taken
into account, more than 30 transitions per peptide might have
to be measured. Therefore, the number of peptides that can be
tested in a single LC-MS analysis is limited. However, the
number of transitions analysed may be increased by using
scheduled SRM (Stahl-Zeng et al, 2007). In such experiments,
the transitions of a speciﬁc peptide are only acquired during a
time window around its elution time. Therefore, using such
time constraints, a much higher number of transitions may be
tested to derive the best performing ones. To perform
scheduled SRM experiments, the scheduling functionality
needs to be supported by the instrument, and the retention
times of the targeted peptides must be known. The retention
The following parameters inﬂuence signal intensity.
(I) Ionization conditions.
Precursor charge state:targeting the predominant chargestate isessential fora sensitive detection. Charge statescan beinferredfrompreviousexperiments
on other ESI instruments. However, ionization devices and experimental conditions (ﬂow rate, solvents, background) can inﬂuence charge state distributions.
Ionsourceparameters:duringtheionizationprocess,singleionsneedtobegenerated.Theprocessofdissolvationanddissociationofionclustersissupported
byavoltagepotentialreferredtoas‘declusteringpotential’(DP),‘fragmentorvoltage’or‘iontransfercapillaryoffsetvoltage’dependingonthemanufacturer.Attoohigh
DP,peptidesarefragmentedalreadyinthesource.FromplottingmanyexperimentallydeterminedDPoptima,apositivelinearcorrelationofprecursor m/zvalueand
DPoptimumwasdetermined(unpublishedresults).AstheDPdisplaysabroadoptimum,individualoptimizationusuallydoesnotresultinasigniﬁcantsignalincrease.
Individual transitions of a peptide have the same DP optimum if they are derived from the same precursor charge state (Figure 3).
(II) Fragmentation conditions.
Fragment ion type: singly charged y ions are the predominant type of fragments generated by CID in a linear collision cell. Only small b ions are usually
observed.Fragmentswithm/zvaluesclosetotheprecursorshouldbeavoidedassuchtransitionsareusuallynoisy.Fragmentswithm/zvaluesabovetheprecursor
generally display the highest selectivity,asthe singly charged chemicalbackground cannot result in fragments with higher m/z than the precursor. In contrast, tryptic
peptideionsarepredominantlydoublyortriplychargedwithonechargeateachterminus.Uponfragmentation,onechargeislostandthereforeapartofthefragments
has an m/z value bigger than the precursor value.
Collision energy: with increasing collision energy, a larger part of the precursor ions is fragmented and fragment ion intensity increases until this increase is
overcompensated bythelossesduetosecondary fragmentationevents(Figure3). Theoptimalcollision energyisapproximately linearlycorrelatedwiththe precursor
massforagivenchargestate.However,particularpeptidesorfragments deviateconsiderablyfromthepredictedvalue.Wefoundthatindividuallyoptimizing collision
energy and declustering potential increased signal response two- to ﬁvefold for every sixth transition (unpublished data).
The easiest and most systematic way of optimizing ionization and fragmentation conditions is to test possible transitions in direct infusion mode andr a m pt h e
parameters as in Figure 3. This process is partly automated by add-ons for the acquisition software. Less ﬁne grained but often sufﬁcient optimization may also be
performed by LC-MS.
Box 3 Factors affecting SRM transition efﬁciency.
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Figure 3 Optimizationoftransitions.Plotofintensityversuscollisionenergy(CE,solidlines)ordeclusteringpotential(DP,dottedlines)forthesixbesttransitions
of two peptides obtained by ramping CE and DP in constant infusion mode. The predicted CEs for the doubly (blue, CE¼0.044 m/zþ5.5) and triply (green,
CE¼0.051 m/zþ0.5) charged precursors are marked by vertical dashed lines.
SRM for quantitative proteomics
V Lange et al
& 2008 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2008 5times can be derived from previous experiments or they might
be predicted by tools like SSRCalc (http://hs2.proteome.ca/
SSRCalc/SSRCalc.html) (Krokhin et al, 2004) if the HPLC
system is ﬁrst calibrated. Alternatively, the retention time of
the targeted peptides may be determined by analysing a
limited number of transitions in a ﬁrst run. This limited set of
transitions may be selected on the basis of available MS/MS
data, or singly charged y ions with m/z values above the m/z
value of the precursor ions may be chosen blindly. Selecting
2–4 y-fragment ions from both doubly and triply charged
precursor ions will usually result in at least one transition with
reasonable performance to derive the retention time informa-
tion for the scheduled experiments.
Limiting the ﬁnal assay to 2–4 transitions per peptide
enablesthetargetingofseveralhundredpeptidesinoneLC-MS
analysis (Box II). The smart selection of transitions as outlined
ensuresthat thisdoesnot affect sensitivityoraccuracybutthat
the highest sensitivity is obtained.
Validation of transitions
In spite of the high speciﬁcity of QQQ SRM analyses achieved
by the two consecutive mass ﬁltering stages, a particular
precursor/fragment combination may not be speciﬁc for a
peptide targeted in a complex sample. A typical case is
illustrated in Figure 4. Unspeciﬁc signals may derive from
other peptides with precursor/fragment ion pairs of similar
masses. These peptides might have closely related sequences
so that part of the transitions are identical. However,
completely unrelated sequences might, by chance, result in
masspairsthataretooclosetobesufﬁcientlyﬁlteredoutinthe
quadrupoles.Inparticular,theoften-not-consideredadditional
peaks due to non-canonical fragments or the natural isotope
distributionincreasethelikelihoodforunspeciﬁcsignals.Such
signals will usually be of lower intensity than the optimized
transitions. However, if SRM is used to target peptides that are
several orders of magnitude less abundant than the most
abundant peptides, such unspeciﬁc signals might still be well
above the detection limit and often even more intense than the
signal for the targeted peptide. As no full mass range spectra,
neither on MS nor on MS/MS level, are acquired in the ﬁnal
SRM analysis, such signals might be easily mistaken as being
derived from the targeted peptide and thus lead to mis-
quantiﬁcations. Therefore, it is important tovalidate the initial
set of transitions to ensure that the quantiﬁed signals indeed
derive from the targeted peptide.
The ﬁrst step of validation is the parallel acquisition of
severaltransitions fora targeted peptide. Atthetimeof peptide
elution, such transitions yield a perfect set of ‘co-eluting’
intensity peaks if theyare derived fromthe same peptide. With
each additional transition, the probability for a random match
is markedly reduced, provided that perfect co-elution is
observed.However,abundantnon-targetpeptideswithsimilar
precursor m/z may generate a broad range of low-intense non-
canonical fragment ions that could be detected by several
transitions and lead to false quantitative data (see Figure 4B,
peak 2 for an example). Therefore, it is highly advised to
complement the parallel acquisition of several transitions by
other means of validation.
AprovenmethodtovalidatetransitionsistoacquireMS/MS
spectra,whicharesubjectedtosequencedatabasesearchingto
conﬁrm that the detected signals derive from the targeted
peptide. This operation is ideally performed on the QQQ
instrument used for the actual SRM experiment using a
protocol referred to as SRM-triggered MS/MS scanning
(Unwin et al, 2005). In such experiments, the instrument is
programmedtoacquireafullfragmentionspectrumwhenever
a signal for a particular transition is detected. The acquired
MS/MS spectra are then compared with the predicted peptide
fragments to assure that the major MS/MS peaks are matched
(Figure 4). This effectively conﬁrms that the detected SRM
signals indeed derive from the targeted peptide. Although this
protocol resembles a classical data-dependent acquisition
mode, the triggering by SRM traces instead of full-scan MS
spectra increases speciﬁcity and thereby allows the identiﬁca-
tion of peptides of low abundance in complex mixtures, which
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Figure 4 Validation of transitions. SRM-triggered MS/MS experiment for the validation of transitions for peptide VFAQFSSFVDSVIAK. (A) SRM traces of ﬁve
transitions.Twopeakswithco-elutingtransitionsareapparentat37.5and43.3min.(B)MS/MSspectratriggeredattheapexofSRMpeaks1(upperpanel)and2(lower
panel).Peaksmatchingtherespectiveyionsarecolouredinred.Eventhoughat43.3min,SRMtransitionintensitiesarehigher,theMS/MSspectraclearlyshowthatthe
targeted peptide is eluting at 37.5min. Utilizing transition intensities at 43.3min without validation would lead to false quantiﬁcation values for the targeted peptide.
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(Lange et al, 2008). However, as SRM is inherently more
sensitive than fullMS/MS spectrum acquisition, thevalidation
of transitions for low-abundance proteins that might be
detectable by SRM remains a challenge, even if SRM-triggered
MS/MS scanning is applied.
The need to acquire MS/MS spectra for the validation of
transitions can be obviated if heavy isotope-labelled peptides
are spiked into the sample before analysis, which match the
sequence of the targeted peptide. Heavy isotope-labelled
peptides (with incorporated
15N and
13C) will exactly co-elute
with the non-labelled target peptides. In addition, the signal
intensity ratios of the transitions are the same for the labelled
and unlabelled peptides. This allows distinguishing the
detection of low-abundant peptides from unspeciﬁc signals
thatbychanceeluteattheexactsameretentiontime.However,
the costs for such heavy labelled peptides might exceed the
resources for projects targeting a large number of proteins. In
such cases, validating peptides by MS/MS spectra acquisition
is a less expensive but more time-intensive alternative. Even
though validation by MS/MS spectrum acquisition cannot
quite reach the excellent sensitivity obtained by spiking
heavy labelled peptides, it has been shown that it allows
precise and reliable quantiﬁcation of peptides that are
below the detection limit of conventional shotgun approaches
(Lange et al, 2008).
Software
The steps described that are required to set up an SRM assay
for multiple proteinsarefundamentallydifferentfromshotgun
proteomics experiments where proteins are identiﬁed from a
sample on the basis of matching MS/MS spectra to databases.
Consequently, the different methods also have different
software requirements. Ideally, a software system to support
the set up of SRM assays would guide the user through the
sequential steps outlined above. Speciﬁcally, the system
should support the following:
  Selection of a protein target set.
  Selection of PTPs representing the target proteins, using a
combination of available data and predictions.
  Selection of transitions. Integration of diverse data types
to derive transitions from MS/MS spectra. Calculation of
canonical fragment transitions and support for transition
selection on the basis of SRM runs.
  Validation of transitions by MS/MS spectra if heavy labelled
peptides are not available.
  Integration of the selection and validation data to support
the ﬂexible export of sets of validated transitions for
quantitative assays.
The selection of protein target sets is highly dependent on the
individual project; a generic solution is thus difﬁcult to
envisage. Several Web-based tools as outlined above may
assist the scientist in the target set selection. Starting with a
target protein set, the recently released software suite TIQAM
(Targeted Identiﬁcation for Quantitative Analysis by multiple
reaction monitoring (MRM)) supports the workﬂow of setting
up an SRM experiment (Lange et al, 2008). TIQAM integrates
proteomic data from local experiments and from the Pepti-
deAtlas database to prioritize PTPs. The selection of transi-
tions on the basis of proteomics data is not yet implemented.
However, TIQAM can generate SRM transition lists and
identify the best performing transitions from SRM pre-
experiments. In addition TIQAM provides a viewer to validate
transitions by SRM-triggered MS/MS experiments. All the
peptide and transition information is stored in a database to
enable smart retrieval of the validated transitions for
quantitative analysis. TIQAM is freely available for download
at http://tools.proteomecenter.org/TIQAM/TIQAM.html.
In addition to TIQAM, several commercial solutions have
been announced supporting the setup of SRM assays for
proteomics. These platform-speciﬁc tools include MRMPilot
(Applied Biosystems), SRM Workﬂow Software (Thermo
Scientiﬁc), Verify
E (Waters) and Optimizer (Agilent Techno-
logies).
Quantiﬁcation by SRM
SRM assay design
The validated and optimized transitions for a speciﬁc peptide
constitute a robust assay that can be used to quantify the
targeted protein(s) by SRM analysis in multiple samples.
Ideally,onecouldtargetallpeptidesoftheproteomeinasingle
LC-MS analysis. However, there is a limit in the number of
transitions that may be quantiﬁed with high sensitivity and
accuracy in a single LC-MS analysis. In SRM mode, the
instrument repeatedly cycles through a list of transitions
spendingadeﬁnedtime,thedwelltime,oneachtransition.For
example, targeting 10 peptides with ﬁve transitions, 20ms
dwell time, results in a cycle time of 1s (10 5 20ms). Thus,
in this situation, every second, an intensity value is recorded
for each of the transitions. The number of transitions
measuredpercycle andthe dwell timearemutuallydependent
at a ﬁxed cycle time. To achieve high sensitivity, the dwell time
has to be long enough to accumulate sufﬁcient signal.
Alternatively, the cycle time might be increased to analyse a
higher number of transitions at a ﬁxed dwell time. However, if
too few data points are recorded over the chromatographic
elution time of a peptide, the accuracy is diminished, as the
peak cannot be correctly reconstructed with too few data
points. To ensure precise LC-MS quantiﬁcation, at least eight
data points should be acquired across the elution proﬁle.
Therefore, the best compromise between dwell time and cycle
time depends on the peak width, which is obtained from
the chromatographic setup. The effect on the quantitative
accuracy as a function of dwell time and cycle time is
illustrated in Figure 5.
To avoid a loss of sensitivity in experiments in which a large
number of transitions is measured, two main strategies have
been used. First, the dwell times for each transition may be
speciﬁcally adjusted to the expected concentration of targeted
peptides, whereby a larger fraction of time is spent on lower
abundance peptides, and shorter dwell times are chosen for
peptides of higher abundance. A complication with this
strategy is that the concentration of a peptide may not be
known a priori and that, in addition, the relationship between
peptide concentration and signal intensity is poorly under-
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targeted peptides without decreasing actual dwell times,
accuracy and sensitivity is to restrict the acquisition of
particular transitions to a window around the elution time of
the corresponding peptide. By scheduling transitions, the full
cycle time is deployed to detect and quantify the peptides
expected to elute in a given time window. Depending on
gradient length, elution peak width and reproducibility of
chromatography, the number of transitions could be increased
by a factor of 5–20 without a decrease in dwell time and
sensitivity (Stahl-Zeng et al, 2007). See Box II for some
examples discussing the number of proteins that may be
quantiﬁed in a single LC-MS analysis.
The detection limit reached will highly depend on the LC
conditions, ionization efﬁciency and instrument used. Wolf-
Yadlin et al (2007) reported a limit of quantiﬁcation of below
3amol peptide loaded on column applying a dwell time of
100ms. As a rule of thumb, a detection limit of 10–50amol
injected on column should be expected for a well-ionizing
peptide with nano-LC and state-of-the-art QQQ instruments.
Normalization
The ﬁnal goal of an SRM experiment is the precise quantiﬁca-
tion of a set of target proteins in a number of biological
samples.Inmanycases,itissufﬁcienttodeterminetherelative
changes of protein amounts. Examples include the quantiﬁca-
tion of differences between healthy and disease or to
determine protein abundance changes in response to changes
intheenvironment,stress,pathwayactivationandsoon.Such
relative quantiﬁcation might be performed on the basis of the
absolute signal intensity of the individual samples. Alterna-
tively, quantiﬁcation may be based on the relative intensities
of the sample analytes versus an internal standard labelled
with stable isotopes. The pros and cons of ‘label free’ versus
‘isotope labelled’ quantiﬁcation are discussed below.
For particular questions regarding systems biology model-
ling, it is advantageous to determine the absolute abundance
ofproteinsinsamples,forexample,ascopiespercellorng/ml.
Absolute concentration cannot be inferred from the signal
intensity directly, as the signal response is peptide dependent
and cannot be predicted. Therefore, precise absolute quanti-
ﬁcation requires that accurately quantiﬁed isotopically la-
belledpeptidesorproteinsbeaddedtothesamples.Incontrast
to the relative quantiﬁcation approach, where a complex
mixture is used as internal standard, only the peptides/pro-
teins targeted for quantiﬁcation are added.
Label-free quantiﬁcation
Relativequantiﬁcation canbebasedonthesignalintensitiesof
speciﬁc SRM transitions. Upon establishment of the SRM
assay, the individual samples are processed and analysed by
LC-MS. Even though the label-free approach seems concep-
tuallyand experimentally simple, preciselabel-free quantiﬁca-
tion is challenging due to variations in signal intensities from
one LC-MS analysis to the other and also within one LC-MS
analysis: A peptide spiked into different backgrounds will
result in different intensities depending on the sample and
timeofanalysis.Themagnitudeoftheﬂuctuationsdependson
the peptide sequence, the background and several experi-
mental factors that cannot be precisely controlled. These
include ﬂuctuations in ionization efﬁciency over time, and
matrixeffects leading toion suppression orenhancement from
co-eluting analytes. These effects are particularly problematic
when many, potentially diverse, samples are analysed in a
study. In an attempt to control for these effects, normalization
is performed in label-free quantitative proteomics with the
assumption that the majority of protein/peptide concentra-
tions in a sample are not changing. However, such normal-
ization can only correct for global shifts and do not
compensate local suppression or enhancement effects on
individual peptides. Despite these limitations, label-free
quantiﬁcation can be successfully performed if the sample
processing is well controlled and the samples are closely
related in background and protein composition. As matrix
effects become more pronounced with higher total peptide
amounts injected, the injected sample amount should be kept
low. In addition, it is essential that several peptides for each
protein are quantiﬁed to avoid false conclusion owing to these
effects.
Stable isotope-based quantiﬁcation
The addition of isotopically labelled internal standards
effectively overcomes the problems of ﬂuctuations in signal
intensity. A common standard—for example, a mixture of the
samples to be analysed—is labelled with heavy stable isotopes
and spiked into the individual samples. Quantiﬁcation is then
not based any longer on the absolute signal intensity, but
rather on the relative intensity of the analyte signals compared
with that of the isotopically labelled internal standard. In such
an approach, each peptide is quantiﬁed relative to the
matching heavy labelled peptide. Selection and validation of
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Figure 5 Quantitative accuracy as a function of dwell time and cycle time.
Quantiﬁcation of a peptide using different settings for dwell time and cycle time.
Reducing the dwell time from 50 to 5ms decreases accuracy. With cycle times of
10 or 20s, the peak height cannot be estimated correctly even though the
accuracy of the individual data points is excellent at 500ms dwell time. Changes
in dwell time do not affect absolute signal intensity as it is plotted normalized as
‘counts per second’.
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sample. For the quantitative analysis, the list of transitions is
supplemented with the corresponding light or heavy transi-
tions resulting in a pair of light/heavy transitions for every
precursor/fragmentcombination.Theisotopelabellingshould
introduce a sufﬁciently large mass difference of both the
precursor and fragment ions to prevent cross talk to the light
transitions. The mass difference required depends on the
resolution of the quadrupoles and the charge state of the
peptide. At a resolution of 0.7 Th FWHM, triply charged
peptides should have a mass difference of at least 5–6Da. To
use isotope-labelling strategies with smaller mass differences,
the quadrupole resolution needs to be tightened, which
decreases sensitivity.
The isotopic label should be introduced in the processing
workﬂow as early as possible to increase the number of steps
that are being controlled and decrease the technical variability
(Ong and Mann, 2005). Most labelling approaches applicable
for quantitative shotgun proteomics, including ICAT (Gygi
etal,1999),SILAC(Ongetal,2002),ICPL(Schmidtetal,2005)
and others (Ong and Mann, 2005) can similarly be used for
SRM-based quantitative experiments if they introduce a
sufﬁciently large mass shift. The main exception to this rule
are isobaric reagents like TMT (Thompson et al, 2003) or
iTRAQ (Ross et al, 2004) where all peptides share the same
reporterionsandareonlydistinguishedbytheprecursormass.
Therefore, peptides with similar precursor masses will
interfere in quantiﬁcation, and the advantages of SRM with
regard to achieving superior selectivity by two-stage ﬁltering
are lost. Despite these limitations, iTRAQ has been success-
fully applied to the analysis of highly enriched samples of low
complexity by SRM(Wolf-Yadlinetal,2007).When choosinga
labelling strategy, it should also be considered that the applied
isotopes do not alter the retention time on reversed-phase
chromatography. Therefore, labelling reagents based on
isotopes of nitrogen, oxygen or carbon are preferred over
those based on deuterium.
Isotope labelling increases the complexity and costs of an
experiment with the beneﬁt of more precise quantiﬁcation.
Matrix effects are largely corrected for by the isotope-labelled
standard. Therefore, a higher sample amount can be loaded
per LC-MS analysis, which increases the dynamic range of the
analysis if the sample amount is not limiting. Taking every-
thing into account, quantiﬁcation using stable isotope label-
ling is the technically less challenging approach despite the
additional preparation steps that are required.
Sample amount normalization
Quantiﬁcation as discussed above yields precise quantitative
values for the relative protein abundances in a set of samples.
To be able to draw conclusions from these samples about a
particular biological system, we have to ensure that the
individual samples reﬂect the system adequately, for example,
thateachsamplerepresentsthesameproportionofthesystem,
the same number of cells and so on. When working with
tissues, the sample amount is commonly based on tissue
weight. This might distort the results when diseased, and
normaltissuesarecomparedwithsubstantiallydifferenttissue
structures.Non-adherent tissue culturecellscould be counted.
However, often the sample amount is based on the total
protein mass as determined by assays, such as Lowry (Lowry
et al, 1951), Bradford (Bradford, 1976) or BCA (Smith et al,
1985),whichareoftennotparticularlyaccurate.Analternative
approach to this challenge of correct starting amounts is to
normalize the samples on the basis of proteins, which are
expected to be constant throughout the experiment. Usually,
the more abundant ‘house keeping’ proteins, which fulﬁl
central cellular functions are good candidates. Even if a few of
these presumably invariant proteins are changing in abun-
dance, normalization is not compromised as long as the group
is sufﬁciently large (410 proteins), and outlier insensitive
statistics (median) are applied to normalize the signal
intensities. These proteins need to be included in the SRM
assay and are quantiﬁed together with the target protein set.
Normalization is performed after acquisition during the
data analysis. For most experiments, such normalization on
invariant proteins yields the most reliable data.
Absolute quantiﬁcation
In particular cases, the relative quantiﬁcation gained from
experiments as outlined above is insufﬁcient. For example, the
determination of copy numbers per cell or the accurate
concentration of a protein in blood requires that individual
isotopically labelled reference peptides or proteins be spiked
into the sample. As the amount of these peptides/proteins is
precisely determined, the absolute amount of the target
protein can be deduced from the relative intensity of the
light/heavy transitions (Barr et al, 1996; Gerber et al, 2003;
Kuhn et al, 2004; Kirkpatrick et al, 2005). However, it is
important to make sure that there are no losses in the process
before the peptides/proteins are added, for example, cell lysis
conditions need to be well optimized to allow concluding
about the copy numbers per cell. This also implies that
peptides/proteins should be spiked in before any kind of
separation or enrichment to control for losses during these
processes. Spiking isotopically labelled proteins has the
advantage that incomplete or unspeciﬁc digestion does not
corrupt the results, as might be the case if isotope-labelled
reference peptides are used.
Peptides/proteins should be spiked in sufﬁcient amount to
produce a relatively intense signal allowing high-precision
quantiﬁcation. However, excessive amounts might saturate
the detector or bleed through into the transitions for the
detection of the light peptide. In addition, stable isotope-
labelled peptides might be contaminated with unlabelled
peptides up to 1–2%. To test for bleed through or contamina-
tion, the heavy peptides should be injected alone and
transitions for both the heavy and light peptides should be
analysed. No signal should be detectable in the transitions for
the light peptides. Ideally, the spiking amounts are derived
from pre-experiments to determine the optimal amount for
each individual peptide. We recommend as starting point to
spike between 10 and 50fmol peptide injected on column, but
this is obviously dependent on instrument and setup.
Several options exist to obtain such peptides/proteins as
internal standards for absolute quantiﬁcation. Custom-speci-
ﬁed peptides with incorporated heavy labelled amino acids
could be ordered by several suppliers. Accurate absolute
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AQUA peptides, relies on the accurate determination of the
peptide concentrations, which is challenging. The most
accurate procedure is amino-acid analysis (AAA) (Macchi
et al, 2000), which relies on highly puriﬁed peptides. A
drawbackofthesesyntheticpeptidesistherelativelyhighcost,
which may become an issue if large numbers of peptides
are required.
Spiking isotopically labelled proteins is required when
absolute quantiﬁcation needs to be combined with separation
and/or enrichment on the protein level, for example, enrich-
ment of proteins by afﬁnity enrichment or antibody capture
(Brun et al, 2007). To obtain isotopically labelled proteins, the
respective genes are cloned into expression vectors and
expressed in in vitro expression systems with part of the
amino acids isotope labelled. Alternatively, in vivo expression
systems might be used with substituted amino acids or using
metabolic labelling in Escherichia coli or yeast. Upon cleanup,
the protein is quantiﬁed by AAA.
Beynon et al have described a recombinant genetic method
togenerateisotopicallylabelledreferencepeptides.Usinggene
synthesis, they create an artiﬁcial protein consisting of
concatenated tryptic peptides, which is expressed as described
for the synthesis of labelled proteins (Beynon et al, 2005;
Pratt et al, 2006). One such construct may be assembled out of
30–50 peptides enabling the quantiﬁcation of many proteins
with this one artiﬁcial protein. As synthetic oligonucleotides
are relatively inexpensive, such ‘QconCAT’ proteins could be
produced at a fraction of the cost of synthetic peptides.
A direct comparison of QconCAT derived and chemically
synthesized peptides revealed the challenges of absolute
quantiﬁcation (Mirzaei et al, 2008). The accuracy of absolute
quantiﬁcation is dependent on the accuracy of quantiﬁcation
of the reference peptides. Incomplete digestion can distort the
peptide amounts obtained from a QconCAT approach. Even
when synthetic peptides are used, which have been quantiﬁed
by AAA, losses of the peptides due to degradation or
modiﬁcation during storage or due to losses during lyophyli-
zation/re-solubilization may introduce a several-fold error
(Mirzaei et al, 2008). Therefore, it is advisable to keep the
peptides in solution after AAA and store aliquots at  801C.
Case studies
Case 1—yeast pathway analysis
Goal of the study
The aim of the study was to establish and test a mathematical
model of the citrate acid cycle in the yeast Saccharomyces
cerevisiae. All the enzymes that constitute the system were to
bequantiﬁedbySRMinproteinextractsfromyeastcellsgrown
under different metabolic conditions (unpublished results).
Selection of protein set
As the pathway has been extensively characterized, the target
protein set of 20proteins is welldeﬁned. The basic structureof
the pathway is derived from the KEGG database, yeast build,
and three additional proteins were included from literature
reports.
Selection of targeted peptides
PTPs for the proteins of interest were derived from PeptideA-
tlas, yeast build (www.peptideatlas.org), which features more
than36000previouslyidentiﬁeduniqueyeastpeptides.Onthe
basis of the number of reports in PeptideAtlas foreach protein,
the three most frequently observed peptides were selected.
Selection and validation of transition
Five transitions per peptide were calculated. They corre-
spondedtoy-fragmentionsandwereprioritizedonthebasisof
the fragment ions observed in the MS/MS consensus spectra
stored in PeptideAtlas. The total of 300 transitions were split
intothreeSRM-triggered MS/MSexperiments, eachperformed
using a 30-min chromatographic gradient. Each SRM transi-
tion was monitored with a 10ms dwell time, followed by
acquisition of two MS/MS spectra triggered by the two highest
SRM signals. MS/MS data were searched against the S.
cerevisiae protein database, and the analysis conﬁrmed the
identiﬁcation of 11 proteins by at least two PTPs each and four
by one PTP. Figure 6A shows validation of the SRM assay for
the abundant protein YJL200C estimated to be expressed at
B5000 copies per cell (Ghaemmaghami et al, 2003). For the
remaining ﬁve proteins, which were not identiﬁed in the ﬁrst
pass, a second attempt was undertaken. Five peptides for each
protein were targeted using six transitions for each of the two
main charge states (doubly and triply charged). The 300
transitions, each acquired for 50ms, were monitored in ﬁve
MRM-triggered MS/MS runs using a 60-min gradient. Data
analysis now conﬁrmed peptides for four additional proteins.
Figure 6B shows validation of the SRM assay for the low-
abundance protein YKL141W estimated to be expressed at
B250 copies per cell (Ghaemmaghami et al, 2003). The
best transitions to be used in quantitative experiments were
either selected on the basis of the MS/MS spectra acquired
in the QQQ instrument or derived from an additional
experiment conducted in scheduled MRM mode in which
20 transitions of the y-ion series with doubly and triply
charged precursor were tested for each peptide, resulting in
about 700 transitions. For each protein, the two best peptides,
and for each peptide, the three transitions with the best
signal-to-noise ratio were selected for quantitative analysis,
resulting in 90 transitions (19 conﬁrmed proteins, 30
peptides, 3 transitions each). For normalization purposes,
30 previously validated transitions corresponding to 10
moderatelyabundantyeastproteinswerealsoincluded,which
were expected to be invariant in the metabolic conditions
used.
Quantitative analysis
The validated SRM assays were used to measure the set of
proteins of interest in six samples, that is, yeast grown in
triplicate under glucose or under ethanol. Yeast cells grown
under glucose were metabolically labelled, and the extracts
from glucose and ethanol growth were combined. The protein
set was quantiﬁed in a single analysis per replicate using
scheduled SRM. Relative quantiﬁcation was obtained by
calculating the ratio between the height of the SRM peaks
derived from the heavy and light version of each peptide.
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sample were corrected using the median of the abundance
changes of the 10 normalization proteins. The analysis
provided the relative abundance changes of the proteins
involved in the citrate acid cycle under the two metabolic
conditionsstudied. The data, optionallycoupled todata sets of
different type(e.g., metabolite concentration data),areused to
validate and improve current mathematical models of the TCA
cycle in S. cerevisiae.
Case 2—biomarker identiﬁcation in plasma
samples
On the basis of a set of candidate proteins, a collection of
plasma samples was screened to identify potential novel
biomarkers for a disease (unpublished results). To be able to
quantify low abundance proteins in plasma, peptides with N-
linkedsugarswerespeciﬁcallyenrichedbysolidphase capture
(Zhang et al, 2003; Stahl-Zeng et al, 2007).
Selection of a target protein set
Preliminary results indicated 50 proteins as potential biomar-
kers for a disease. In addition, ten moderately abundant
plasma proteins were selected for normalization.
Selection of peptides
On the basis of the number of observations in the human
plasma build of the PeptideAtlas (www.peptideatlas.org),
for each protein, one peptide with N-glycosylation site was
selected. Peptides with non-tryptic or missed cleavages were
not considered. In addition, peptides with potential chemical
modiﬁcations were avoided whenever possible. The heavy
isotope-labelled homologues of the 60 peptides were custom-
synthesized and quantiﬁed.
Selection of SRM transitions
To optimize transitions, the peptides were mixed at high
concentration (250fmol/ml in 50% acetonitrile) in batches of
10 and analysed by infusion in nano-ESI mode (Box III). SRM
transitions for the y and yþþ series of doubly and triply
charged precursor ions were calculated with TIQAM (30–50
transitions per peptide). Then, collision energy and ion source
parameters were ramped while analysing the approximately
400transitionsperbatch(Figure3).Foreachpeptide,thethree
best performing transitions with associated parameters were
selected for the ﬁnal quantitative assay.
Quantiﬁcation
To derive the ideal spiking amount and the retention time,
a representative sample processed by N-glycocapture was
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Figure6 Validationoftransitionsfor yeastproteins. SRM-triggered MS/MSexperiment forthe validationoftransitionsfor ahigh- (A)andalow-abundance (B)protein
of S. cerevisiae. Owing to the low abundance of protein YKL141W (B), the SRM traces for the corresponding peptide AAIAEEQILNK were of low intensity.
Nevertheless, the acquired MS/MS spectrum conﬁrmed the identity of the peptide with high conﬁdence.
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per labelled peptide injected on column. On the basis of the
signal intensities observed, the peptides were spiked into 100
samples for the actual analyses at a reduced concentration to
yield a signal intensity of 50000cps peak height (average of
three transitions). The quantitative analyses were performed
by scheduled SRM using a cycle time of 2s with three
transitions for each of the heavy and light peptides resulting in
a total of 360 transitions (Figure 7).
Normalization
Quantiﬁcation was based on the peak height, which we found
more reliable for low-intense signals. For each peptide, the
heavy/light transition pair with the best signal-to-noise ratio
was selected for quantiﬁcation. Two steps of normalization
were performed: ﬁrst, the ratio of light/heavy transition was
calculated. Second, a normalization vector was calculated
from the results of the 10 moderately abundant proteins. Each
sample was corrected by the median of the normalized
abundance of these 10 proteins to correct for global shifts in
the individual samples.
Results
A total of 30 candidate biomarkers were successfully
quantiﬁed over a set of 100 samples in this experiment. The
remaining 20 candidates could not be detected in the plasma
samples as the protein concentration was below the detection
limit. Taking into account the estimated recovery of the
glycocapture process and the spiked peptide amount, the
concentration of the potential biomarker proteins in plasma
was estimated, ranging from 5 to 100ng/ml. Several candi-
dates showed statistically signiﬁcant differences between
samples from healthy and diseased people.
Outlook
Shotgun proteomics has revolutionized the speed and depth of
protein identiﬁcation from complex mixtures. However, many
biological questions remain unanswered by qualitative data
alone, thus the demand for quantitative proteomic data has
been steadily rising. Several strategies, including stable
isotope labelling, were developed in the past decade to enable
quantitative proteomic studies. Despite these advancements,
technological limitations remain. First, in shotgun proteomics,
only the more highly abundant part of the proteome is
reproducibly identiﬁed. Less-abundant peptides are only
sporadically identiﬁed resulting in missing data points in
quantitative data sets. Second, sample fractionation, a key to
increasing proteome coverage in proteomic studies, is more
difﬁcult to implement and requires prohibitive analysis time
for larger quantitative studies that include numerous samples.
The targeted SRM-based approach therefore ideally comple-
ments shotgun workﬂows. On the basis of a comprehensive
map derived by shotgun proteomics, PTPs of protein sets of
interest can be selected to generate speciﬁc SRM transitions.
Upon validation, these proteins can be quantiﬁed reliably in
multiple samples. This supports the growing demand by
systems biology for consistent quantitative data sets of
multiple samples challenged under varying conditions. It is
also expected that SRM can bridge the gap between biomarker
discovery, usually performed on few samples, and validation
by antibody-based approaches, which are costly and slow to
develop. When combining efﬁcient enrichment strategies with
SRM, detection limits in the low ng/ml range in plasma can be
achieved under ideal conditions at a considerable throughput
of 100 samples per week. If, however, higher throughput and/
orhighersensitivityarerequired,antibody-based technologies
should be considered.
Currently, setting up SRM assays for higher number of
proteins remains challenging and requires substantial time
investment despite the recently developed software solutions
to support this process (Lange et al, 2008). Frequently, the
same proteins are of interest for multiple projects, and the
redundant transition selection in several laboratories is a
waste of valuable resources. Thus, validated transitions
should be stored in centralized databases, together with
optimized experimental parameters, to be accessible to the
proteomic community. Along these lines we have generated
‘MRMAtlas’ (http://www.mrmatlas.org/), a publicly accessi-
ble database of validated SRM assays currently covering about
1500 proteins of S. cerevisiae (Picotti et al, 2008). Each
validated SRM assay includes all the required parameters to
quantify the targeted protein on a QQQ MS, such as the
following: m/z of the precursor peptide ion, charge state, m/z
of the fragment ions with the highest signal intensities,
suggested collision energy and relative intensities of fragment
ion signals, calculated hydrophobicity and observed elution
times,bothasameasureofrelativeretention timeonreversed-
phase separation. To ensure speciﬁcity of the assays, each
peptide was validated by MS/MS spectra, which are accessible
online. We intend to further extend the MRMAtlas to other
species and encourage the submission of validated high-
quality SRM assays. A remaining need is to concur on a
standardized protocol to report normalized elution times, one
10000
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13 14 15
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50000
13 14 15
Intensity (cps)
Time (min)
Figure 7 Quantiﬁcation of proteins in plasma. A total of 360 transitions
were acquired by scheduled SRM to quantify 60 peptides in plasma
samples following glycocapture. Traces for one peptide in 1 out of 100 analysed
samples are shown. On the basis of the heavy isotope-labelled peptide (dashed
lines), the concentration of the endogenous protein (solid lines) was estimated to
be 5ng/ml.
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set of common reference standards should serve as elution
time landmarks and thus account for HPLC column and
system variability.
The setup of SRM assays is largely simpliﬁed by isotopically
labelledpeptides.Asthesebecomeroutinelyavailableatlower
prices, their use in larger scale projects is conceivable. As
many researchers, particularly in the biomarker ﬁeld, will
require the same sets of PTPs, suppliers may soon offer panels
of speciﬁc isotopically labelled peptides in combination with
optimized SRM parameters. As the quantities required as
internal standards are several orders lower than the amount
produced in one chemical synthesis, such peptide kits will
become affordable. Alternatively, where unique peptides are
required, the QconCAT strategy may, once commercialized,
allow the production of personalized QconCAT proteins
covering peptides for a full set of targeted proteins at the cost
of a microarray experiment. Therefore, we expect the
availability of isotopically labelled peptides to increase
signiﬁcantly by one way or another.
As SRM ﬁnds morewidespreaduse in proteomics,several of
the remaining obstacles will be solved. In addition to the
quantiﬁcation of proteinabundance, SRM has a great potential
for the reliable quantiﬁcation of post-translational modiﬁca-
tions. In conclusion, SRM strategies appear as an excellent
match to the requirements of systems biology, not only
allowing quantitative analysis of low-abundant proteins, but
also delivering reliably quantitative data when proteins are
analysed across multiple samples.
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